期刊文献+

阿司匹林联合氯吡格雷应用对血小板聚集率影响的Meta分析 被引量:23

Meta-Analysis of Effect on Platelet Aggregation by Aspirin and Clopidogrel
下载PDF
导出
摘要 目的对有关阿司匹林、氯吡格雷对血小板聚集率影响相关文献进行系统评价,为临床用药提供参考。方法查阅国内外已公开发表的有关阿司匹林、氯吡格雷对血小板聚集率影响的临床随机对照试验文献,主要以血小板聚集率为评价指标,以Cochrane协作网的软件RevMan4.2进行Meta分析。结果共有5篇文献符合入选标准,总样本数为198。以二磷酸腺苷为聚集剂,阿司匹林联合氯吡格雷组与阿司匹林组的有效率差值为-26.59,95%可信区间(-38.30,-14.87),位于无效线左侧,具有统计学意义。以胶原蛋白为聚集剂,阿司匹林联合氯吡格雷组与阿司匹林组有效率差值为-16.05,95%可信区间为(-27.37,-4.74)位于无效线的左侧,具有统计学意义。结论阿司匹林联合氯吡格雷对血小板聚集率的影响优于单用阿司匹林,服用氯吡格雷负荷剂量300mg,则影响不大。 Objective A systematic review of the relative references of Aspirin plus Clopidogrel on the platelet aggregation, aimed at providing the reference basis for clinic use of drug. Method Search the clinical randomized controlled trials references of Aspirin plus Clopidogrel on the platelet aggregation published at home and abroad, mainly use platelet aggregation as result indicators, use software RevMan4.2 in Coehrane Cooperation Net to process meta-analysis. Results Total 5 pieces of references paper selected, the total sample number is 198.Use ADP as aggregation agent, the D-value between effective rate of Aspirin plus Clopldogrel group and that of Aspirin group is -26.59,95% confidence interval (-38.30,-14.87) locates on the left side of ineffective line, which has statistical significance. Use Collagen as aggregation agent, the D-value between effective rate of Aspirin plus Clopidogrel group and Aspirin group is -16.05,95% confidenee interval(-27.37,-4.74) locates on the left side of ineffective line, which has statistical significance. Conclusion Compared with Aspirin alone, the effect of Clopidogrel plus Aspirin on the platelet aggregation is more superior, and 300 mg loading-dose of Clopidogrel does not make the difference.
作者 曾颖 许姿敏
出处 《循证医学》 CSCD 2008年第3期162-166,共5页 The Journal of Evidence-Based Medicine
关键词 阿司匹林 氯吡格雷 血小板 聚集率 META分析 Aspirin Clopidogrel platelet aggregation meta-analysis
  • 相关文献

参考文献9

  • 1韩雅玲.冠心病抗血小板治疗[J].武警医学,2006,17(3):163-165. 被引量:8
  • 2Cooke GE, Liu-Stratton Y, Ferketich AK, et al. Effect of platelet antigen polymorphism on platelet inhibition by Aspirin, Clopidogrel, or their combination [J]. J Am Coil Cardiol, 2006,47 ( 3 ) : 541-546.
  • 3Serebruany VL, Malinin AI, Ziai W, et al. Effects of Clopidogrel and Aspirin in combination versus Aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: For the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial [J]. Stroke, 2005,36 (10) : 2289-2292.
  • 4Serebruany VL, Malinin AI, Jerome SD,et al. Effects of Clopidogrel and Aspirin combination heart failure: The Plavix Use for Treatment of Congestive Heart Failure (PLUTO-CHF) trial[J] Am Heart, 2003,146(4) :713-720.
  • 5Dorr G, Schmidt G, Grafe M, et al. Effects of combined therapy with Clopidogrel and Acetylsalicylic Acid on platelet glycoprotein expression and aggregation [J]. J Cardiovasc Pharmacol, 2002,39(4) : 523-532.
  • 6Cadroy Y, Bossavy JP, Thalamas C, et al. Early potent antithrombotic effect with combined Aspirin and a loading dose of Clopidogrel on experimental arterial thrombogenesis in humans[J]. Circulation, 2000,101 (24) :2823-2828
  • 7Jadad AR, Moore A, Carrol D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? [J]. Control Clin Trials, 1996,17( 1 ) :1-12.
  • 8The Active Steering Committee. Rationale and design of ACTIVE: The atrial fibrillation Clopidogrel trial with irbesartan for prevention of vascular events [J]. Am Heart J, 2006,151 (6) : 1187-1193.
  • 9张微微.比较氯吡格雷与阿司匹林加埃索美拉唑对复发性溃疡出血的预防作用的点评[J].实用心脑肺血管病杂志,2006,14(1):22-22. 被引量:3

二级参考文献10

  • 1Yusuf S,Zhao F,Mehta SR et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med,2001,345(7):494-502
  • 2Mehta SR,Yusuf S,Peters RJ et al.Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention:the PCI-CURE study.Lancet,2001,358 (9281):527-533
  • 3Steinhubl SR,Berger PB,Mann JT 3rd et al.Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:a randomized controlled trial.JAMA,2002,288(19):2411 -2420
  • 4Douglas Jr JS,Holmes Jr DR,Kereiakes D.Cilostazol forestenosis trial:a randomized,double-blind study following coronary artery stent implantation.Late Breaking Clinical Trial Abstracts,AHA,2003.Circulation,2003,108(21) 2723
  • 5The CAPRIE Steering Committee.A randomised,blinded,trial of clopidogrel versus aspirin in patients at risk ofischaemic events.Lancet,1996,348(9038):1329-1339
  • 6Hennekens CH,Schror K,Weisman S et al.Terms and Conditions:Semantic Complexity and Aspirin Resistance.Circulation,2004,1i0(12):1706-1708
  • 7Lau WC,Waskell LA,Watkins PB et al.Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation:a new drug-drug inte.raction.Circulation,2003,107(1):32-37
  • 8Saw J,Steinhubl SR,Berger PB et al.Lack of Adverse Clopidogrel-Atorvastatin Clinical Interaction From Secondary Analysis of a Randomized,Placebo-Controlled Clopidogrel Trial.Circulation,2003,108(8):921-924
  • 9Hoekstra JW,Pollack Jr CV,Roe MT et al.Improving the Care of Patients with Non-ST-elevation Acute Coronary Syndromes in the Emergency Department:The CRUSADEInitiative.Acad Emerg Med,2002,9(11):1146-1155
  • 10Budaj A,Brieger D,Steg PG et al.Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes:Insights from the Global Registry of Acute Coronary Events (GRACE).Am Heart J,2003,146(6):999-1006

共引文献9

同被引文献192

引证文献23

二级引证文献397

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部